Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

(2012) J. C. Jennette et al.   ARTHRITIS AND RHEUMATISM

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center

(2012) Rodrigo Cartin-Ceba et al.   ARTHRITIS AND RHEUMATISM

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis

(2012) Rona M. Smith et al.   ARTHRITIS AND RHEUMATISM

Efficacy and Safety of Rituximab Treatment in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitides: Results from a German Registry (GRAID)

(2012) P. ROLL et al.   JOURNAL OF RHEUMATOLOGY

Complications of long-term therapy for ANCA-associated systemic vasculitis

(2012) Nadezhda Wall et al.   Nature Reviews Nephrology

Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides

(2012) Nils Venhoff et al.   PLoS One

Off-Trial Evaluation of the B cell-Targeting Treatment in the Refractory Cases of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: Long-Term Follow-Up from a Single Centre

(2012) R. Pullerits et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up

(2011) Lorraine Harper et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

(2011) Julia U Holle et al.   ANNALS OF THE RHEUMATIC DISEASES

Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis

(2011) C. A. Langford   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis

(2011) C. ROUBAUD-BAUDRON et al.   JOURNAL OF RHEUMATOLOGY

Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients

(2011) M Wendt et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis

(2010) Randi Y. Leavitt et al.   ARTHRITIS AND RHEUMATISM

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

(2010) E. P. Rhee et al.   Clinical Journal of the American Society of Nephrology

Does rituximab increase the incidence of infectious complications? A narrative review

(2010) Theodoros Kelesidis et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Diagnostic strategy for patients with hypogammaglobulinemia in rheumatology

(2010) Maxime Samson et al.   JOINT BONE SPINE

Rituximab or Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

(2009) Rachel B. Jones et al.   ARTHRITIS AND RHEUMATISM

Serum Immunoglobulins and Risk of Infection: How Low Can You Go?

(2008) Daniel E. Furst   SEMINARS IN ARTHRITIS AND RHEUMATISM